Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. SEPTIVON (chlorhexidine (gluconate de))
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

SEPTIVON (chlorhexidine (gluconate de))

Medicine - Posted on Feb 19 2016 - Updated on Jun 12 2019
Active substance (DCI)
  • chlorhexidine (gluconate de)
history (3)
  • 2/3/16

    SEPTIVON (chlorhexidine (gluconate de))

    Maintien du remboursement dans les mêmes conditions
    icône flèche
  • 12/1/10

    SEPTIVON (chlorhexidine (gluconate de))

    SEPTIVON (chlorhexidine (gluconate de))
    icône flèche
  • 9/15/04

    SEPTIVON 0,5 %, solution pour application cutanée Flacons de 250 et 500 ml (Codes CIP : 312 932 6 (flacon de 250 mL) et 312 933 2 (flacon de 500 mL))

    SEPTIVON 0,5 %, solution pour application cutanée Flacons de 250 et 500 ml (Codes CIP : 312 932 6 (flacon de 250 mL) et 312 933 2 (flacon de 500 mL))
    icône flèche
Technical information
ATC code
  • D08AC02
Manufacturer
OMEGA PHARMA FRANCE
Presentation

SEPTIVON 1,5 %, solution pour application cutanée (code CIS : 67127581) 1 flacon polyéthylène haute densité (PEHD) de 250 ml - Code CIP : 3400936416628

All our publications
    Bacterial infections Drug therapy Skin and connective tissue diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
eNq9mF1v2jAUhu/5FVHu8wGFQqdAtbF2Q2o1Ros27aYyyQHMXDv1Bx/79XMI1dLJUVtT95I4OefE5/VzXpKcb++JtwYuMKN9vxnGvgc0ZRmmi74/vb0Mev75oJGs0BpVbuuGcdhs+V5KkBB9v1gNZ4CoCH9eX30G/Txwf9DwEjZbQSqf3KckJuFXJJbXKC/u8ZI1w5l3D3LJsr6fK7m/6iVCcl3FYMP4b5GjFJLocKW6urprV68nURHsBVGVAH6F6MIYFKhVzFRxDlQOkYQF4ztj6Hl61+p1T+O4Z5UCiwkIpngKYySXY87WOIPMnAkRAVZJ5pvsBviagCySGINHq/ReWAVHK7SdwMPIXPRHvTqUWxnEQbPbaXdacbfbjNtnVql4ZavM4tEvEeU5z+5aZ712Kz6JgEYCconXjAbpkjC+hC3WhwGCBVEpo7q1QQaWrRszLhFx1DQshk/l5ygPh4dnxZFhkRO0C1cit90qxJFeBq4h4e5Fije45RpbRO/Zf/GpIiR6ZdXTA1QcVVwwa8gUlTVsuZzYbsSQUQnb+o7a4VBuD1rEIN4u7B9GzaNgrGYEp7bE00xSIOR0MqoH3juy4hMSMOXuYPED04xtxNtDqNp0R9Xne44ag+r+NIsGnTY7Hesz9ksrrGY+XSjOcog0nrA4hjojOmfH8kaL1hzqUbLvpda9l2IpIlDjpgJLMmmZPpo/ZwfB3SErF4xBv1zc2qrnuwK+u9n/NIbGWb/adztyuxgHWq61tb9e/CUDXmC1272Tlp2quRkxSylz8SGKNptNuEQiEEhvVjjn7z0hKjPb3f8AJ8agNEolZR2VPivH5+saaHskn7MOx9rhw/MH223MIbmCI3pR0tsZY0cXb4/tf17YWdnjJ4xxl2bvW5HEjLoyTGpmdkvHDgrdWnrJNSO+zee45gtNrTSTqPw6NGgkUfFlaND4CyqFG+w=
EeL3L7Pp9q3FpVDR